Aspirin and cancer risk is in the news again—and the link is
still unclear. Two studies published early online in the Journal
of Clinical Oncology evaluated the relationship between aspirin
and cancer risk—one indicated that aspirin does not appear to
reduce the risk of developing breast cancer, while the other
found that regular aspirin use was associated with a reduced
risk of dying from prostate cancer. Researchers continue to
evaluate the link between cancer risk and aspirin, especially as
a growing body of evidence suggests that aspirin may reduce the
risk of several types of cancer, with particularly strong
evidence for colorectal cancer. Not all studies have found a
benefit, however, and any potential benefits of aspirin must be
weighed against risks such as bleeding. Current clinical
guidelines recommend daily aspirin for some individuals to
protect against cardiovascular disease. The data continues to
roll in regarding aspirin and cancer. Researchers from Brigham
and Women’s Hospital in Boston used d